BACKGROUND: The Amplatzer Septal Occluder (ASO)(AGA Medical Corp, Golden Valley,
Minn) has gained wide acceptance for transcatheter closure of atrial septal defect (ASD). We …

The impact of device size choice on closure results was analyzed in 138 (101 females, 37
males; age 0.5–84.0 years) consecutive patients who underwent transcatheter closure of the …

This study reports the results of a Japanese clinical trial of transcatheter closure of atrial
septal defects (ASD) using the Amplatzer septal occluder (ASO). Thirty-five patients with …

Aim: To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal
defects (ASD) with the Amplatzer septal occluder. Methods: 236 consecutive patients with a …

To judge whether an Amplatzer Septal Occluder (ASO) can be used as a safe therapy
instead of surgery for closure of large atrial septal defects> 25 mm in diameter, we report our …

Aims Transcatheter closure of secundum atrial septal defects (ASD) with the Amplatzer
septal occluder (ASO) has become a standard procedure in most pediatric and adult …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …

Little is known about the efficacy and safety of the 40 mm Amplatzer septal occluder (ASO).
Thirty‐three patients (22 female, 11 male) with a large secundum atrial septal defect (ASD) …

Objectives: The aim of this study was to assess long-term results of percutaneous closure of
secundum-type atrial septal defect (ASD II) using Amplatzer septal occluders (ASO) …

Transcatheter closure of secundum atrial septal defect (ASD) using clamshell or buttoned
devices is accompanied by a high incidence of residual shunt. Recently, a new self …